共 8 条
- [2] 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O726 - O727
- [3] 7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione acetic acid solvate ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O2676 - O2677
- [4] WY-49,051, 7-[3-[4-(DIPHENYLMETHOXY)-1-PIPERIDINYL]PROPYL]-3,7-DIHYDRO-1,3-DIMETHYL-1H-PURINE-2-6-DIONE, A NOVEL AGENT WITH ANTIHISTAMINE PROPERTIES FASEB JOURNAL, 1988, 2 (05): : A1405 - A1405
- [5] Experimental studies on the antitussive properties of the new xanthine derivative 1H-purine-2,6-dione, 3,7-dihydro-3-methyl-7[(5-methyl-1,2,4-oxadiazol-3-yl)methyl] .1. In vivo demonstration of the effects on animal models of cough and of mucociliary clearance ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1997, 47 (04): : 395 - 400
- [6] Experimental studies on the antitussive properties of the new xanthine derivative 1H-purine-2,6-dione, 3,7-dihydro-3-methyl-7[(5-methyl-1,2,4-oxadiazol-3-yl)methyl] -: 2nd communication:: Investigations on theophylline-like activities ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1997, 47 (12): : 1358 - 1363
- [7] Experimental studies on the antitussive properties of the new xanthine derivative 1H-purine-2,6-dione, 3,7-dihydro-3-methyl-7[(5-methyl-1,2,4-oxadiazol-3-yl)methyl] -: 3rd Communication:: Examinations on opioid mechanisms and physical drug dependence ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1998, 48 (12): : 1147 - 1155
- [8] STRUCTURES OF BINUCLEAR COPPER(II) CHLOROACETATE COMPLEXES - TETRAKIS-(MU-MONOCHLOROACETATO-O,O')-BIS[(3,7-DIHYDRO-1,3,7-TRIMETHYL-1H-PURINE-2,6-DIONE)COPPER(II)], [CU2(C2H2CLO2)4(C8H10N4O2)2] ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 1985, 41 (AUG): : 1160 - 1162